Treatment of Prion Disease: Is it possible? A Review
DOI:
https://doi.org/10.35516/jmj.v59i2.2211Keywords:
Prion disease, virus, Creutzfeldt Jacob Disease, animals, humans, therapyAbstract
Just when scientists believed they had a stronghold on human micro-organisms, up come a new group of disease called prion disease. This new category of disease is fatal in both infected humans and animals. First detected as scrapie in sheep and goats in as early as 1730s, it has evolved and possibly mutated to now infect humans who consume meats of sheep, goats and cows, among others. This review article attempts to look at existing and potential treatment for this currently incurable disease. It is hoped that this article will give scientists hope to continue their tireless struggle to find a cure for this illness.
References
Hedlin P, Taschuk R, Potter A, Griebel P, Napper S. Detection and control of prion diseases in food animals. ISRN veterinary science. 2012 Feb 29;2012.
B. Sigurdsson, “Rida, a chronic encephalitis of sheep: with general remarks on infections which develop slowly and some of their special characteristics,” British Veterinary Journal, vol. 110, pp. 341–354, 1954.
I. Klatzo, D. C. Gajdusek, and V. Zigas, “Pathology of kuru,” Laboratory Investigation, vol. 8, no. 4, pp. 799–847, 1959.
D. C. Gajdusek, C. J. Gibbs, and M. Alpers, “Experimental transmission of a kuru-like syndrome to chimpanzees,” Nature, vol. 209, no. 5025, pp. 794–796, 1966.
C. J. Gibbs Jr., D. C. Gajdusek, D. M. Asher et al., “Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee,” Science, vol. 161, no. 3839, pp. 388– 389, 1968. [5] H. B. Parry, “Scrapie: a transmissible hereditary disease of sheep,” Heredity, vol. 17, pp. 75–105, 1962.
Centers for Disease Control and Prevention. Creutzfeldt-Jakob Disease, Classic (CJD). Available from?.
https://www.cdc.gov/prions/cjd/treatment.html
Gajdusek, D. C. 1996. Infectious amyloids: subacute spongiform encephalopathies as transmissible cerebral amyloidoses, p. 2851–2900. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. LippincottRaven Publishers, Philadelphia, Pa.
Prusiner, S. B. 1996. Prions, p. 2901–2950. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
Harris DA. Cellular biology of prion diseases. Clinical microbiology reviews. 1999 Jul 1;12(3):429-44.
Prusiner, S. B., and K. K. Hsiao. 1994. Human prion diseases. Ann. Neurol. 35:385–395.
Le Bras A. A new drug to treat prion diseases. Lab animal. 2019 Apr;48(4):116.
Skinner PJ, Kim HO, Bryant D, Kinzel NJ, Reilly C, Priola SA, Ward AE, Goodman PA, Olson K, Seelig DM. Treatment of prion disease with heterologous prion proteins. PLoS One. 2015 Jul 2;10(7):e0131993.
Raymond GJ, Zhao HT, Race B, Raymond LD, Williams K, Swayze EE, Graffam S, Le J, Caron T, Stathopoulos J, O’Keefe R. Antisense oligonucleotides extend survival of prion-infected mice. JCI insight. 2019 Aug 22;4(16).
Yung L, Huang Y, Lessard P, Legname G, Lin ET, Baldwin M, Prusiner SB, Ryou C, Guglielmo BJ. Pharmacokinetics of quinacrine in the treatment of prion disease. BMC infectious diseases. 2004 Dec;4(1):53.
Glatzel M, Ott PM, Lindner T, et al. 2003. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol. 2:757–63.
Weissmann C, Aguzzi A. Approaches to therapy of prion diseases. Annu. Rev. Med.. 2005 Feb 18;56:321-44.
Cashman NR, Caughey B. Prion diseases—close to effective therapy?. Nature Reviews Drug Discovery. 2004 Oct;3(10):874.
Stewart LA, Rydzewska LH, Keogh GF, Knight RS. Systematic review of therapeutic interventions in human prion disease. Neurology. 2008 Apr 8;70(15):1272-81.
